Injection of Dorsal Scapular n at Different Levels, Dose it Make Difference?
CompletedPhase 2, Phase 3NCT04693312
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Dorsal scapular nerve (DSN) entrapment syndrome is an under-recognized cause of neck and shoulder pain. DSN injuries can be the origin of a well-defined chronic pain syndrome, often referred to as DSN syndrome. DSN syndrome is often characterized by a dull ache along the medial border of the scapula.
Study details
- Official title
- Injection of Dorsal Scapular n at Different Levels, Dose it Make Difference?
- Conditions
- Interventions
- Drug: Depo medrol
- Sponsor
- Assiut University
- Start date
- 2020-01-01
- Primary completion
- 2020-03-01
- Sex
- All
- Age range
- from 20 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * scapular pain Exclusion Criteria: * cervical radiculopathy
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04693312